A carregar...
Ceftolozane/Tazobactam for Resistant Drugs Pseudomonas aeruginosa Respiratory Infections: A Systematic Literature Review of the Real-World Evidence
Background: Ceftolozane/tazobactam (C/T) is a β-lactam/β-lactamase inhibitor combination that mainly targets Gram-negative bacteria. The current international guidelines recommend including C/T treatment in the empirical therapy for hospital-acquired pneumonia (HAP) and ventilator-associated pneumon...
Na minha lista:
| Publicado no: | Life (Basel) |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8225018/ https://ncbi.nlm.nih.gov/pubmed/34073847 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/life11060474 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|